You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin signalisation

Showing 1 - 25 of 8,056
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fragile X Syndrome Trial in Sherbrooke (Metformin)

Completed
  • Fragile X Syndrome
  • Sherbrooke, Quebec, Canada
    Université de Sherbrooke
Feb 1, 2021

Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)

Not yet recruiting
  • Central Insulin Resistance
  • +2 more
  • Human nasal insulin
  • Placebo
  • (no location specified)
May 12, 2023

Diabetes Trial (Insulin Degludec and Insulin Aspart)

Not yet recruiting
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • (no location specified)
Apr 4, 2023

Education, Patient Trial in Izmir (Video-assisted training)

Active, not recruiting
  • Education, Patient
  • Video-assisted training
  • İzmir, Menemen, Turkey
    izmir Bakircay University
Jun 21, 2023

To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in

Completed
  • To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
  • Glargine and regular insulin versus NPH and regular insulin
  • Lahore, Punjab, Pakistan
    Pediatric endocrine and diabetes section, Pediatric department,
Jan 29, 2023

Type 1 Diabetes Trial (Semaglutide weekly injection)

Not yet recruiting
  • Type 1 Diabetes
  • Semaglutide weekly injection
  • (no location specified)
Sep 21, 2023

Insulin Resistance, Polycystic Ovary Syndrome, Hyperinsulinism Trial in Houston

Not yet recruiting
  • Insulin Resistance
  • +4 more
    • Houston, Texas
      Lilli Health
    Jul 10, 2023

    Diabetes, Type I Trial in Padova (Simulation of an insulin pump failure)

    Not yet recruiting
    • Diabetes Mellitus, Type I
    • Simulation of an insulin pump failure
    • Padova, PD, Italy
      Azienda Ospedaliera di Padova
    Nov 22, 2023

    Hyperkalemia, Potassium Imbalance, Electrolyte Imbalance Trial in Seeb (Insulin regular, Dextrose 50, salbutamol)

    Not yet recruiting
    • Hyperkalemia
    • +3 more
    • Insulin regular
    • +2 more
    • Seeb, Muscat, Oman
      Sultan Qaboos University hospital
    Sep 11, 2023

    type1diabetes, Diabetes, Type 1 Trial in Montreal (Pramlintide, Insulin Lispro, Insulin aspart)

    Not yet recruiting
    • type1diabetes
    • Diabetes Mellitus, Type 1
    • Montreal, Quebec, Canada
      Research Institute of the McGill University Health Center
    Sep 18, 2023

    Diabetes, Critical Illness, Hyperglycemia Trial in Riyadh (Degludec insulin)

    Recruiting
    • Diabetes Mellitus
    • +2 more
    • Degludec insulin
    • Riyadh, Saudi Arabia
      King Faisal Specialist Hospital & Research Centre
    Sep 24, 2023

    Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • Afrezza
    • +3 more
    • (no location specified)
    Jun 6, 2023

    DKA Trial in Saint Paul (Insulin Glargine)

    Recruiting
    • DKA
    • Insulin Glargine
    • Saint Paul, Minnesota
      Regions Hospital
    Aug 21, 2023

    Type 2 Diabetes Trial in Charlottesville (Control-IQ use in Type 2 Diabetes under basal insulin injections)

    Not yet recruiting
    • Type 2 Diabetes
    • Control-IQ use in Type 2 Diabetes under basal insulin injections
    • Charlottesville, Virginia
      University of Virginia Center for Diabetes Technology
    Sep 5, 2023

    Alzheimer, Mild Cognitive Impairment, Positron Emission Tomography Trial in Turku (FDG-PET study)

    Recruiting
    • Alzheimer Disease
    • +2 more
    • FDG-PET study
    • Turku, Finland
      Turku PET Centre
    Oct 30, 2023

    Insulin Resistance Trial in Poznan (the group GS (probiotic), the group GP ())

    Completed
    • Insulin Resistance
    • the group GS (probiotic)
    • the group GP (placebo)
    • Poznań, Poland
      Poznan University of Physical Education
    Oct 13, 2023

    Polycystic Ovary Syndrome, Chiglitazar, Metformin Trial in Shenyang (Chiglitazar, Metformin)

    Enrolling by invitation
    • Polycystic Ovary Syndrome
    • +2 more
    • Shenyang, Liaoning, China
      Shengjing Hospital of China Medical University
    Nov 5, 2023

    Asthma, Obesity, Insulin Resistance Trial in Birmingham (Probiotic, Placebo)

    Not yet recruiting
    • Asthma
    • +2 more
    • Probiotic
    • Placebo
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jul 7, 2023

    Regarding Glucose Metrics, Sleep, and Health Economics

    Completed
    • Type 1 Diabetes
    • Tandem Control-IQ
    • Kungsbacka, Region Of Halland, Sweden
      The hospital of Halland Kungsbacka
    Jul 28, 2023

    Type2diabetes Trial in Çankaya (Upper extremity aerobic exercise training, Control Group)

    Not yet recruiting
    • Type2diabetes
    • Upper extremity aerobic exercise training
    • Control Group
    • Çankaya, Ankara, Turkey
      Gazi University, Faculty of Health Sciences, Department of Physi
    Nov 13, 2023

    Type 2 Diabetes Trial in New York, Charlottesville (Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in

    Not yet recruiting
    • Type 2 Diabetes
    • Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs
    • New York, New York
    • +1 more
    Nov 2, 2023

    Diabetes, Adrenal Insufficiency, Polyglandular Autoimmune Syndrome Trial in Gothenburg (OD dual-release Hydrocortisone, TID

    Not yet recruiting
    • Diabetes Mellitus
    • +2 more
    • OD dual-release Hydrocortisone
    • TID Hydrocortisone
    • Gothenburg, Sweden
      Sahlgrenska University Hospital
    Jan 27, 2023

    Type 1 Diabetes Trial in Trondheim (Glucagon)

    Recruiting
    • Type 1 Diabetes
    • Trondheim, Norway
      Department of Endocrinology, St. Olavs Hospital
    Jul 17, 2023

    Insulin Resistance, Healthy, Obesity Trial in Nashville (Phentolamine, Saline, Sodium Nitroprusside)

    Recruiting
    • Insulin Resistance
    • +2 more
    • Nashville, Tennessee
      Autonomic Dysfunction Center
    Jan 2, 2023

    Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the

    Not yet recruiting
    • Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients
    • +6 more
    • Chiglitazar sodium
    • Chiglitazar placebo
    • Guangzhou, Guangdong, China
      the First Affiliated Hospital of Sun Yat-sen University
    Aug 17, 2023